HK2 and prostate cancer: In agreement with these cell experiments, the histopathological analysis showed that in prostate cancer patient samples, upregulation of both HK2 and SENP1 is associated with poor prognosis and poor response to docetaxel-based chemotherapy (Fig. 6d).